Create a narrative

Abbott Laboratories Community

NYSE:ABT Community

1 Narratives written by author
0 Comments on narratives written by author
186 Fair Values set on narratives written by author

Create a narrative

Abbott Laboratories

AN

AnalystConsensusTarget

Consensus Narrative from 25 Analysts

Tariffs In 2025 And Declining Diagnostics Will Narrow Net Margins

Key Takeaways Tariffs and VBP challenges in China may hinder revenue growth, despite mitigation strategies and exploration of new business opportunities outside China. Significant investments in new market opportunities, such as nucleic acid testing and advanced medical technologies, may compress margins before driving long-term growth.

US$140.41

FV

8.4% undervalued

7.39%

Revenue growth p.a.

3

0

109

Updated